Results 161 to 170 of about 12,485 (214)

Withdrawal of antitumour necrosis factor in inflammatory bowel disease patients in remission: a randomised placebo-controlled clinical trial of GETECCU. [PDF]

Gut
Gisbert JP, Donday MG, Riestra S, Lucendo AJ, Benítez JM, Navarro-Llavat M, Barrio J, Morales-Alvarado VJ, Rivero M, Busquets D, Leo Carnerero E, Merino O, Nantes Castillejo Ó, Navarro P, Van Domselaar M, Gutiérrez A, Alonso-Abreu I, Mejuto R, Fernández-Salazar L, Iborra M, Martín-Arranz MD, Pineda JR, Sampedro MJ, Serra Nilsson K, Bouhmidi A, Batista L, Muñoz Villafranca C, Rodríguez-Lago I, Ceballos D, Guerra I, Mañosa M, Marín Jiménez I, Torrella E, Vera Mendoza M, Casanova MJ, de Francisco R, Arias-González L, Marín Pedrosa S, García-Bosch O, García-Alonso FJ, Delgado-Guillena P, García MJ, Torrealba L, Núñez-Ortiz A, Vicuña Arregui M, Bosca-Watts MM, Blázquez I, Acosta D, Garre A, Baldán M, Martínez C, Barreiro-de Acosta M, Domènech E, Esteve M, García-Sánchez V, Nos P, Panés J, Chaparro M, EXIT Study group of GETECCU.   +58 more
europepmc   +1 more source

[Synchronous medullary and mucinous tumor in the right colon: case report] [PDF]

Rev Fac Cien Med Univ Nac Cordoba
Bastidas J, Posada H, Amante M, Pestalardo L, Muthular M, Stawkowy L, Petracchi E, Yazyi F.   +7 more
europepmc   +1 more source

Segundo Congreso Nacional de Patología Digestiva [PDF]

, 2015
J. F.
core   +1 more source

Competence network inflammatory bowel diseases in Germany: 25 years of interdisciplinary and cross-sectoral research and knowledge transfer across all levels of IBD care. [PDF]

Ther Adv Gastroenterol
Bokemeyer B, Plachta-Danielzik S, Helwig U, Beuchert P, Schreiber S.   +4 more
europepmc   +1 more source

Efficacy of a mechanism-based psychological intervention for persistent gastrointestinal symptoms in ulcerative colitis and irritable bowel syndrome: results of a three-arm randomised controlled trial (SOMA.GUT-RCT). [PDF]

EClinicalMedicine
Maehder K, Peters L, Hübener S, Matysiak A, Huber S, Toussaint A, Zapf A, Vettorazzi E, Weber P, Stahlmann K, Andresen V, Nestoriuc Y, Lohse AW, Löwe B.   +13 more
europepmc   +1 more source

[Application of advanced treatment in chronic inflammatory bowel diseases]. [PDF]

Inn Med (Heidelb)
Misselwitz B, Zeißig S, Schreiber S, Dignass A.   +3 more
europepmc   +1 more source

Corrigendum: Is a rare <i>CXCL8</i> gene variant a new possible cause or course factor of inflammatory bowel disease? [PDF]

Front Immunol
Gabryel M, Zakerska-Banaszak O, Ladziak K, Hubert KA, Baturo A, Suszynska-Zajczyk J, Hryhorowicz M, Dobrowolska A, Skrzypczak-Zielinska M.   +8 more
europepmc   +1 more source

Noticias [PDF]

Reial Acadèmia de Medicina de les Illes Balears
core  

Respuesta inmunitaria humoral en pacientes con Colitis Ulcerosa

Revista Cubana de Investigaciones Biomédicas
Olga Marina Hano García, María Fernanda Estupiñán Sosa, Deyanira la Rosa Hernández, Licet González Fabián   +3 more
doaj  

Some of the next articles are maybe not open access.

Related searches:

Colitis ulcerosa

Allgemeine Homöopathische Zeitung, 2016
Zusammenfassung. Die Colitis ulcerosa ist eine chronische immunologische Darmerkrankung mit einer Entzündung der Mukosa und teilweise der Submukosa. Sie verläuft schubweise und betrifft im Gegensatz zum Morbus Crohn ausschliesslich das Kolon. Die vielzitierte Ausnahme der kurzstreckigen Beteiligung des terminalen Ileums (sogenannte backwash ileitis ...
Roose, Laura Maria, D'cunja, Jaya, Biedermann, Luc   +2 more
exaly   +5 more sources